In vitro immunosuppressive effects of methotrexate and azathioprine on Langerhans cells

Archives of Dermatological Research

Volumn 289, Issue 2, 1997, Pages 94-97

  Liu, Han Nan ^a,b,c   Wong, Chu Kwan ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Azathioprine; Immunosuppression; Langerhans cell; Methotrexate; Mixed lymphocyte reaction

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ARTICLE; HUMAN; HUMAN CELL; LANGERHANS CELL; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL;

AZATHIOPRINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LANGERHANS CELLS; LYMPHOCYTE TRANSFUSION; METHOTREXATE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031026130     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050161     Document Type: Article

References (33)

1. Bergfelt L (1993) Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study. Acta Derm Venereol Suppl (Stockh) 180:1-37
2. Bergfelt L, Larko O, Blohme I (1993) Skin disease in immunosuppressed patients in relation to epidermal Langerhans cells. Acta Derm Venereol 73:330-334
3. Halliday GM, Knight BA, Muller HK (1986) Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants. Br J Dermatol 114:83-89
4. Furue M, Katz SI (1989) Direct effects of glucocorticosteroids on epidermal Langerhans cells. J Invest Dermatol 92:342-347
5. Teunissen MB, De Jager MH, Kapsenberg ML, Bos JD (1991) Inhibitory effect of cyclosporin A in antigen and alloantigen presenting capacity of human epidermal Langerhans cells. Br J Dermatol 125:309-316
6. Petzelbauer P, Wolff K (1992) Effects of cyclosporin in resident and passenger immune cells of normal human skin and UV-induced erythema reactions. Br J Dermatol 127:560-565
7. Bergfelt L (1993) UV-related skin conditions and Langerhans cell populations in human skin. Acta Derm Venereol 73:194-196
8. Tang A, Udey MC (1992) Effects of ultraviolet radiation on murine epidermal Langerhans cells: doses of ultraviolet radiation that modulate ICAM-1 (CD54) expression and inhibit Langerhans cell function cause delayed cytotoxicity in vitro. J Invest Dermatol 99:83-89
9. Belter S, Aberer W, Stingl-Gazze LA, Wolff K, Schuler G, Stingl G (1981) A new method for Langerhans enrichment. J Invest Dermatol 76:427
10. Bjercke S, Lea T, Braathen LR, Thorsby E (1984) Enrichment of human epidermal Langerhans dendritic cells. Scand J Immunol 19:255-263
11. Liu HN, Chang YT, Wong CK (1994) Enrichment of unlabelled human Langerhans cells by modified discontinuous Ficoll-Metrizoate density medium and following Langerhans cell culture. Clin Exp Dermatol 19:113-117
12. Teunissen MBM, Wormmeester J, Kapsenberg ML, Bos JD (1988) Enrichment of unlabeled human Langerhans cells from epidermal cell suspensions by discontinuous density gradient centrifugation. J Invest Dermatol 91:358-362
13. Jablonska S, Chorzelski T (1970) Immunosuppressants in the treatment of pemphigus. Br J Dermatol 83:315-323
14. Kaur S, Kanwar AJ (1990) Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 29:371-374
15. Ginzler EK, Sharon E, Diamond H, Kaplan D (1975) Long-term maintenance therapy with azathioprine in systemic lupus erythematosus. Arthritis Rheum 18:27-34
16. Schulz EJ, Menter MA (1971) Treatment of discoid and subacute lupus erythematosus with cyclophosphamide. Br J Dermatol 85 (Suppl 7):60-65
17. Benson MD, Aldo MA, Washington DC (1973) Azathioprine therapy in polymyositis. Arch Intern Med 132:447-451
18. Callen JP, af Ekenstam E (1987) Cutaneous leukocytoclastic vasculitis. Clinical experience in 44 patients. South Med J 80: 848-851
19. Fauci AS, Katz P, Haynes BF, Wolff SM (1979) Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301:235-238
20. Morrison JGL, Schultz EJ (1978) Treatment of eczema with cyclophosphamide and azathioprine. Br J Dermatol 98:203-207
21. Younger IR, Harris DWS, Colver GB (1991) Azathioprine in dermatology. J Am Acad Dermatol 25:281-286
22. Ellis CN, Fradin MS, Messana JM, Brown MD, Siegel MT, Hartley AH, Rocher LL, Sheeler S, Hamilton TA, Parish TG, et al. (1991) Cyclosporine for plaque-type psoriasis. N Engl J Med 324:277-284
23. Ellis CN, Gorsulowsky DC, Hamilton TA, et al. (1986) Cyclosporine improved psoriasis in a double-blind study. JAMA 256:3110-3116
24. Ho VC, Zloty DM (1993) Immunosuppressive agents in dermatology. Dermatol Clin 11:73-85
25. Stern RS, Laird N (1994) The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study. Cancer 73:2759-2764
26. Voogd CE (1989) Azathioprine, a genotoxic agent to be considered non-genotoxic in man. Muta Res 221:133-152
27. Perm I (1984) Cancer in immunosuppressed patients. Transplant Proc 16:492-494
28. Chabner BA, Allegra CJ, Curt GA, Calabresi P (1996) Anti-neoplastic agents. In: Hardman JG, Oilman AG, Bimbird LE (eds) Goodman & Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York. pp1243-1247
29. Espana A, Redondo, Fernandez AL, Zabala M, Herreros J, Llorens R, Quintanilla E (1995) Skin cancer in heart transplant recipients. J Am Acad Dermatol 32:458-465
30. Liliemark J, Pettersson B, Lafolie P, Zweig T, Peterson C (1990) Determination of plasma azathioprine and 6-mercaptopurine in patients with rheumatoid arthritis treated with oral azathioprine. Thera Drug Monit 12:339-343
31. el-Yazigi A, Wahab FA (1993) Pharmacokinetics of azathioprine after repeated oral and single intravenous administration. J Clin Pharmacol 33:522-526
32. Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dunn DL (1994) De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. Clin Transplant 8:388-395
33. Green C, Hawk JLM (1993) Cutaneous malignancy related to cyclosporin A therapy. Clin Exp Dermatol 18:30-31